In a case that could shape the future of psychedelic medicine, a palliative care physician is challenging a DEA decision that bars him from prescribing psilocybin to late-stage cancer patients.
Dozens of California studies on psychedelics or addiction treatment that need to be vetted by a little-known government panel are now in limbo. Some scientists want to abolish the panel entirely.
The move to legalize psychedelics in California appears to be entering a new phase, with incremental steps to permit the drugs in therapeutic settings.